Esoteric Testing Market Analysis

  • Report ID: 3832
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Esoteric Testing Market Segmentation:

Test Type Segment Analysis

The infectious disease segment is estimated to gain the largest market share over the projected time frame, attributed to the increasing prevalence of several types of infectious diseases in all age groups. For instance, as per a survey, the frequency of visits to medical offices in the United States for infectious and parasitic disorders grew to around 10.5 million in 2019. Infectious disorders are illnesses caused by harmful microbes such as viruses, fungi, or parasites. Infectious diseases are typically transmitted from person to person, by contaminated water or food, or through insect bites. Infectious diseases are relatively frequent all around the world, however, some are more prevalent than others. Inadequate sanitation and poor hygiene contribute to the transmission of infectious diseases. Moreover, the surge in COVID-19 diagnostics has radically increased across the globe which is also projected to spur the growth of the market. Hence, the worldwide surge in the spread of such diseases is estimated to expand the growth of the segment.

Technology Segment Analysis

The global esoteric testing market is also segmented and analyzed for demand and supply by technology into flow cytometry, chemiluminescence immunoassay, mass spectrometry, radio immunoassay, DNA sequencing, real-time polymerase chain reaction, and others. Amongst these segments, the chemiluminescence immunoassay segment is expected to garner a significant share. The growth of the segment can be attributed to the high-performance levels, good precision, and low detection limits of this technology of esoteric testing. Apart from these, the expanding ratio of autoimmune disorders along with the increasing concern regarding the early diagnosis of diseases are also anticipated to boost the segment growth further in the coming years. For instance, more than 10 million people in the United States, or 5% of the population, are affected by all autoimmune disorders. Moreover, rising research and development activities associated with the diagnosis of autoimmune diseases, where chemiluminescence immunoassay is highly used to test the symptoms, are also predicted to boost the market segment growth in the future. On the other hand, the global esoteric testing market is also segmented and analyzed for demand and supply by end-user into independent & reference laboratories, and hospital laboratories. Amongst these two segments, the independent & reference laboratories segment is projected to witness a notable CAGR during the forecast period, owing to the rising count of laboratories throughout the worldwide, coupled with the surge in the frequency of testing, and escalating digitalization of diagnostic laboratories across the globe.   

Our in-depth analysis of the global market includes the following segments:

         By Test Type

  • Infectious Disease
  • Endocrinology
  • Oncology
  • Toxicology
  • Immunology
  • Genetic Testing
  • Others

            By Technology

  • Flow Cytometry
  • Chemiluminescence Immunoassay
  • Mass Spectrometry
  • Radio Immunoassay
  • DNA Sequencing
  • Real Time Polymerase Chain Reaction
  • Others

            By End-User

  • Independent & Reference Laboratories
  • Hospital Laboratories

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of esoteric testing is evaluated at USD 31.88 billion.

The global esoteric testing market size was worth around USD 29.2 billion in 2025 and is set to register a CAGR of more than 10.2%, exceeding USD 77.13 billion revenue by 2035.

North America esoteric testing market will dominate over 41.5% share by 2035, driven by well-established healthcare infrastructure and rising chronic conditions.

Key players in the market include H.U. Group Holdings, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Healius Limited, Sonic Healthcare Limited, Thyrocare Technologies Limited, Fulgent Genetics, Inc., Kindstar Globalgene Technology, Inc., OPKO Health, Inc., ARUP Laboratories.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos